<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:30:41Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2195754" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2195754</identifier><datestamp>2008-04-16</datestamp><setSpec>jexpmed</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Exp Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Exp. Med</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Experimental Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-1007</issn>
      <issn pub-type="epub">1540-9538</issn>
      <publisher>
        <publisher-name>The Rockefeller University Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2195754</article-id>
      <article-id pub-id-type="pmcid">PMC2195754</article-id>
      <article-id pub-id-type="pmc-uid">2195754</article-id>
      <article-id pub-id-type="pmid">10637284</article-id>
      <article-id pub-id-type="publisher-id">99-1554</article-id>
      <article-id pub-id-type="pmid">10637284</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Definitive Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clonal Deleterious Mutations in the IÎºbÎ± Gene in the Malignant Cells in Hodgkin's Lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jungnickel</surname>
            <given-names>Berit</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Staratschek-Jox</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="b">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BrÃ¤uninger</surname>
            <given-names>Andreas</given-names>
          </name>
          <xref ref-type="aff" rid="c">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Spieker</surname>
            <given-names>Tilmann</given-names>
          </name>
          <xref ref-type="aff" rid="c">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wolf</surname>
            <given-names>JÃ¼rgen</given-names>
          </name>
          <xref ref-type="aff" rid="b">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diehl</surname>
            <given-names>Volker</given-names>
          </name>
          <xref ref-type="aff" rid="b">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansmann</surname>
            <given-names>Martin-Leo</given-names>
          </name>
          <xref ref-type="aff" rid="c">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rajewsky</surname>
            <given-names>Klaus</given-names>
          </name>
          <xref ref-type="aff" rid="a">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KÃ¼ppers</surname>
            <given-names>Ralf</given-names>
          </name>
          <address>
            <addr-line>University of Cologne, Department of Internal Medicine I, Joseph-Stelzmannstr. 9, LFI E4 R706, 50931 Cologne, Germany.</addr-line>
            <fax>49-221-478-6383</fax>
            <phone>49-221-478-4490</phone>
          </address>
          <email>rkuppers@mac.genetik.uni-koeln.de</email>
          <xref ref-type="aff" rid="a">a</xref>
          <xref ref-type="aff" rid="b">b</xref>
        </contrib>
        <aff id="a">
<label>a</label>Institute for Genetics, University of Cologne, 50931 Cologne, Germany</aff>
        <aff id="b">
<label>b</label>Department of Internal Medicine I, University of Cologne, 50931 Cologne, Germany</aff>
        <aff id="c">
<label>c</label>Department of Pathology, University of Frankfurt, 60596 Frankfurt, Germany</aff>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>17</day>
        <month>1</month>
        <year>2000</year>
      </pub-date>
      <volume>191</volume>
      <issue>2</issue>
      <fpage>395</fpage>
      <lpage>402</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>9</month>
          <year>1999</year>
        </date>
        <date date-type="rev-request">
          <day>26</day>
          <month>10</month>
          <year>1999</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>10</month>
          <year>1999</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2000 The Rockefeller University Press</copyright-statement>
        <copyright-year>2000</copyright-year>
        <copyright-holder>The Rockefeller University Press</copyright-holder>
        <license license-type="openaccess">
          <license-p>This article is distributed under the terms of an AttributionâNoncommercialâShare AlikeâNo Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms">http://www.rupress.org/terms</ext-link>). After six months it is available under a Creative Commons License (AttributionâNoncommercialâShare Alike 4.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Members of the nuclear factor (NF)-ÎºB family of transcription factors play a crucial role in cellular activation, immune responses, and oncogenesis. In most cells, they are kept inactive in the cytosol by complex formation with members of the inhibitor of NF-ÎºB (IÎºB) family, whose degradation activates NF-ÎºB in response to diverse stimuli. In Hodgkin's lymphoma (HL), high constitutive nuclear activity of NF-ÎºB is characteristic of the malignant Hodgkin and Reed-Sternberg (H/RS) cells, which occur at low number in a background of nonneoplastic inflammatory cells. In single H/RS cells micromanipulated from histological sections of HL, we detect clonal deleterious somatic mutations in the IÎºBÎ± gene in two of three Epstein-Barr virus (EBV)-negative cases but not in two EBV-positive cases (in which a viral oncogene may account for NF-ÎºB activation). There was no evidence for IÎºBÎ± mutations in two non-HL entities or in normal germinal center B cells. This study establishes deleterious IÎºBÎ± mutations as the first recurrent genetic defect found in H/RS cells, indicating a role of IÎºBÎ± defects in the pathogenesis of HL and implying that IÎºBÎ± is a tumor suppressor gene.</p>
      </abstract>
      <kwd-group>
        <kwd>Hodgkin's lymphoma</kwd>
        <kwd>IÎºBÎ±</kwd>
        <kwd>nuclear factor ÎºB</kwd>
        <kwd>tumor suppressor gene</kwd>
        <kwd>Reed-Sternberg cell</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Hodgkin's lymphoma (HL) is the most common type of malignant lymphoma in the Western world. It is distinguished from other tumors by a peculiar histological presentation: the giant, often bi- or multinucleated malignant cells, termed Hodgkin and Reed-Sternberg (H/RS) cells, constitute &lt;1% of all cells in the tumor tissue. They are surrounded by an excess of inflammatory cells, e.g., lymphocytes, macrophages, and eosinophils, which are believed to be drawn into the tumor by a deregulated immune reaction precipitated by the H/RS cells <xref ref-type="bib" rid="R1">1</xref>.</p>
      <p>Investigations into the molecular biology of H/RS cells are hampered by their scarcity in the tumor tissue. A detailed analysis of their origin was made possible by the combination of micromanipulation of H/RS cells from frozen tissue sections with PCR amplification of genes from single cells <xref ref-type="bib" rid="R2">2</xref>
<xref ref-type="bib" rid="R3">3</xref>. Amplification of V(D)J gene rearrangements on the loci coding for IgH and IgL chains revealed the clonal nature of H/RS cells and their derivation from mature B cells. Deleterious (âcripplingâ) somatic mutations found in some of these rearrangements indicated that the B cell precursors of H/RS cells resided within the germinal center, and have acquired the capacity to survive loss of B cell receptor expression, an event that would otherwise invariably lead to death by apoptosis of a germinal center B cell <xref ref-type="bib" rid="R4">4</xref>. Consequently, resistance to apoptosis must play a crucial role in the pathogenesis of the malignant cells.</p>
      <p>Despite the impressive progress made in the treatment of HL, the pathogenesis of the tumor and in particular the molecular events leading to transformation of the malignant cells remain to be elucidated. Even though studies on HL-derived tissue or cell lines suggested that p53 mutations or bcl-2 translocations might play a role in the pathogenesis of HL, neither of these ideas could be validated when primary H/RS cells were investigated <xref ref-type="bib" rid="R5">5</xref>
<xref ref-type="bib" rid="R6">6</xref>. In some cases of HL, the H/RS cells carry EBV and express EBV-encoded proteins such as the oncogenic latent membrane protein 1 (LMP-1 <xref ref-type="bib" rid="R7">7</xref>). However, most cases of HL prevalent among young adults in Western countries are EBV-negative. The distinct epidemiology of these cases has led to various speculations about their pathogenesis, but no other virus or recurrent transforming genetic defect has been identified to date.</p>
      <p>Studies in several HL-derived cell lines identified constitutive nuclear factor (NF)-ÎºB activity as their characteristic feature <xref ref-type="bib" rid="R8">8</xref>, suggesting a role for NF-ÎºB in the pathogenesis of HL. In line with this idea, inhibition of NF-ÎºB activity in some of these cell lines led to increased susceptibility to apoptosis and impaired tumorigenicity in nude mice <xref ref-type="bib" rid="R9">9</xref>. NF-ÎºB activity is mediated by the Rel/NF-ÎºB family of transcription factors, members of which are expressed in virtually all mammalian cells. In most cells, NF-ÎºB is retained in an inactive form in the cytoplasm by binding to members of the IÎºB family of proteins (for a review, see reference 10). A variety of stimuli leads to the degradation of IÎºBs, which allows nuclear translocation of NF-ÎºB and target gene activation. Most inducible NF-ÎºB responses in the cell are mediated by the classical NF-ÎºB heterodimer p50/p65 and are of a transient nature, an effect mainly due to the rapid resynthesis of IÎºBÎ±, the prototypic member of the IÎºB family. Target genes activated by NF-ÎºB include factors involved in apoptosis resistance, cell activation, and proliferation, as well as cyto- and chemokines involved in immunoregulation <xref ref-type="bib" rid="R10">10</xref>
<xref ref-type="bib" rid="R11">11</xref>. In fact, NF-ÎºB has been likened to a master switch of immune responses, and accumulating evidence indicates in addition a pivotal role of NF-ÎºB in several pathways of malignant transformation. In lymphoid malignancies, for example, NF-ÎºB deregulation may occur due to chromosomal translocations involving the <italic>nfkb2</italic> or <italic>bcl3</italic> loci <xref ref-type="bib" rid="R11">11</xref>
<xref ref-type="bib" rid="R12">12</xref>.</p>
      <p>In view of this, the demonstration that constitutive activity of p65 is also a characteristic feature of the H/RS cells in primary cases of HL <xref ref-type="bib" rid="R9">9</xref> is highly relevant for the pathogenesis of the tumor. In EBV-positive cases, this NF-ÎºB activity may be caused by the expression of the viral oncogene LMP-1 on the H/RS cells. An intriguing alternative cause of constitutive NF-ÎºB activity has been proposed on the basis of data from two HL-derived cell lines, which show defects in the expression of IÎºBÎ± protein <xref ref-type="bib" rid="R13">13</xref> due to mutations in the IÎºBÎ± gene <xref ref-type="bib" rid="R14">14</xref>. However, these cell lines have been established from treated and relapsed patients at late stages of the disease <xref ref-type="bib" rid="R15">15</xref>, and it is unclear whether they are indeed derived from the rare H/RS cells. Likewise, a mutant IÎºBÎ± fragment could be amplified from a minute fraction of a partially purified H/RS cell population from a relapsed case of HL <xref ref-type="bib" rid="R14">14</xref>. Again, it is unclear whether the mutation is derived from the malignant cells. Even if this were the case, it is stated by the authors that this mutation cannot be present in all H/RS cells <xref ref-type="bib" rid="R14">14</xref>; its relevance for the NF-ÎºB activity in the H/RS cell clone is thus doubtful. Therefore, it is an open question whether IÎºBÎ± defects play any role in the pathogenetic process that leads to HL.</p>
      <p>For many human malignancies, insight into the mechanisms of tumorigenesis has come from the recurrent detection of genetic defects that are common to all cells of the malignant clone and can already be found in primary tumors (rather than sporadic mutations scattered in the tumor that may arise due to its high mutability or upon treatment). It is the clonal nature of mutations that implicates their involvement in the process of malignant transformationâa central criterion for the identification of an oncogene or tumor suppressor gene. In this study, we have analyzed the role of IÎºBÎ± defects in HL on the basis of this concept.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Analysis of HL-derived Cell Lines.</title>
        <p>IÎºBÎ± protein was detected by Western blot with an antibody directed against the COOH terminus (C-21; Santa Cruz Biotechnology). The IÎºBÎ± coding region was amplified from oligo(dT)-primed cDNA with primers P0S (5â²-AGCGAGGAAGCAGCGCGCAG-3â²) and P2AS (5â²-AGTCCATGTTCTTTCAGCCCC-3â²), using the Expand PCR system (Boehringer Mannheim) supplemented with 2 mM MgCl<sub>2</sub> and 2% DMSO. Cycling conditions were 5 min 95Â°C; 40 cycles of 50 s at 95Â°C, 30 s at 63Â°C, and 90 s at 72Â°C; and a final 10 min at 72Â°C.</p>
      </sec>
      <sec>
        <title>Primary Cases.</title>
        <p>The primary cases were as follows: <xref ref-type="bib" rid="R1">1</xref> mandibular lymph node biopsy from a 12-yr-old female patient, primary diagnosis of nodular sclerosing HL; <xref ref-type="bib" rid="R2">2</xref> axillary lymph node biopsy from a 20-yr-old male patient, primary diagnosis of nodular sclerosing HL; <xref ref-type="bib" rid="R3">3</xref> supraclavicular lymph node biopsy from a 35-yr-old male patient, primary diagnosis of nodular sclerosing HL; <xref ref-type="bib" rid="R4">4</xref> cervical lymph node biopsy from a 29-yr-old male patient, relapsed mixed cellularity HL, primary diagnosis was 3 yr prior; and <xref ref-type="bib" rid="R5">5</xref> abdominal lymph node biopsy from a 36-yr-old male patient, primary diagnosis of mixed cellularity HL.</p>
      </sec>
      <sec>
        <title>Analysis of Primary Cases.</title>
        <p>Total genomic DNA was isolated from sections of the lymph nodes using the QIAamp kit. Single H/RS cells were micromanipulated from 5-Î¼m histological sections stained for CD30, and stored in 20 Î¼l of 1Ã Expand PCR buffer (Boehringer Mannheim) at â20Â°C. Thawed samples were incubated with 0.25 mg/ml proteinase K (Boehringer Mannheim) for 2 h at 50Â°C and then 8 min at 96Â°C. For amplification of exons 1 and 2, samples were adjusted to 50-Î¼l reaction mixes supplemented with 2.5 mM MgCl<sub>2</sub>, 4% DMSO, 50 nM each of primers IÎºB1b (5â²-TGGTCTGACTGGCTTGGAAATTC-3â²) and IÎºB1c (5â²-CATCGCTGGTCCCCCGGCTC-3â²), and 16.6 nM of primers IÎºB2a (5â²-CGAAGTCCCCGGTTGCATAAGG-3â²) and IÎºB2c (5â²-GGATCTGGGGTGACTCTGCTAC-3â²). After incubation for 5 min at 95Â°C, 35 cycles of 50 s at 95Â°C, 30 s at 65Â°C, and 90 s at 72Â°C were followed by 10 min at 72Â°C. For amplification of exons 3â6, samples were supplemented with 2 mM MgCl<sub>2</sub>, 50 nM each of primers IÎºB3a (5â²-CCTGTCTAGGAGGAGCAGCAC-3â²), IÎºB3d (5â²-TAGGAGTTTAAGCTCTTGCCTGGA-3â²), IÎºB4b (5â²-AAAGAATAGGTGAAAGGAGTGAGG-3â²), and IÎºB4c (5â²-ATAAGCACGAGGAGCCTGACTCA-3â²), and 16.6 nM each of primers IÎºB5a (5â²-AGCAGAAATTCCAAATGCAGCCAT-3â²), IÎºB5d (5â²-GGAGCAGCTCTAGGGGCCTG-3â²), IÎºB6a (5â²-GAGTTATTTCCAGTAGTGGCCTC-3â²), and IÎºB6d (5â²-GGGGTCAGTCACTCGAAGCAC-3â²). PCR was as above, except that the annealing temperature was 63Â°C. Seminested amplification of the individual exons was as follows: for exon 1, the Expandâ¢ PCR system was supplemented with 2 mM MgCl<sub>2</sub>, 4% DMSO, and 125 nM each of primers IÎºB1b and IÎºB1r (5â²-GCGTCCCGCCCTCCCGACGA-3â²); for exon 2, the Expandâ¢ PCR system was supplemented with 2 mM MgCl<sub>2</sub> and 125 nM each of primers IÎºB2b (5â²-AGTACAGGTCGTTCCGAGCTGG-3â²) and IÎºB2c; exons 3â6 were amplified using standard Taq DNA polymerase in 2 mM MgCl<sub>2</sub>; 125 nM each of primers IÎºB3b (5â²-AACCAGGAGACACGGGTTGAGG-3â²) and IÎºB3d, IÎºB4b2 (5â²-GAGGGTTGAAACAGGTGGTTAT-3â²) and IÎºB4c, IÎºB5a and IÎºB5c (5â²-GGAGGGTGAAGGGAATGGCAC-3â²), and IÎºB6b (5â²-CCC-ATCCCGGTAGCTTGGCAG-3â²) and IÎºB6d were included, respectively. After 5 min at 95Â°C, 45 cycles of 50 s at 95Â°C, 30 s at 65Â°C, and 90 s at 72Â°C were followed by 10 min at 72Â°C. Amplification of products spanning several exons was performed accordingly. The same conditions were also used for amplification of the IÎºBÎ± exons from total genomic DNA of cell populations and cell lines. Products were gel-purified and sequenced directly using the ABI BigDye system.</p>
        <p>For amplification of exons 1 and 4 from aliquoted DNA, single H/RS cells were incubated with 0.25 mg/ml proteinase K (Boehringer Mannheim) in 120 Î¼l 1Ã PCR buffer containing 1 ng/Î¼l 5S rRNA and incubated at 50Â°C for 14 h. After gentle mixing by 10 pipetting steps, 20-Î¼l aliquots of the reactions were heated to 96Â°C for 8 min and subsequently adjusted to 50-Î¼l Expand PCR reactions supplemented with 2 mM MgCl<sub>2</sub>, 4% DMSO, 125 nM each of primers IÎºB1s (5â²-CTGAAGAAGGAGCGGCTACTG-3â²), IÎºB1c, and IÎºB4b, and 62.5 nM of primer IÎºB5c. After incubation for 5 min at 95Â°C, 35 cycles of 50 s at 95Â°C, 30 s at 63Â°C, and 90 s at 72Â°C were followed by 10 min at 72Â°C. Seminested amplification of exon 1 (the Expandâ¢ system was supplemented with 2 mM MgCl<sub>2</sub>, 4% DMSO, and 125 nM each of primers IÎºB1s and IÎºB1r) and exon 4 (standard Taq DNA polymerase was used in 2 mM MgCl<sub>2</sub> and 125 nM each of primers IÎºB4b2 and IÎºB5c) was essentially as above.</p>
      </sec>
      <sec>
        <title>Analysis of Normal B Cell Populations.</title>
        <p>Tonsillar mononuclear cells were sequentially incubated with CD27-FITC (PharMingen) and anti-FITC microbeads (Miltenyi Biotec), then passed over a CS-MACS column (Miltenyi Biotec). CD27<sup>â</sup> cells were sequentially incubated with mouse antiâhuman IgD (Southern Biotechnology Associates) and antiâmouse IgG2a/b microbeads (Miltenyi Biotec), and IgD<sup>+</sup> cells were isolated via an LS-MACS column (Miltenyi Biotec). Tonsillar mononuclear cells from the same patient were incubated consecutively with rat antiâhuman CD77 (Immunotech), mouse antiârat IgM (Serotec), and antiâmouse IgG1 microbeads (Miltenyi Biotec), and CD77<sup>+</sup> cells were isolated via an LS-MACS column. Total genomic DNA was isolated from both cell populations, and exons 1 and 2 of IÎºBÎ± were amplified as above using PfuTurboâ¢ polymerase (Stratagene). After 35 cycles, PCR products were purified, incubated with 200 Î¼M dNTPs, and Taq polymerase (GIBCO BRL) for 15 min at 72Â°C, and cloned into the pGEM-T Easy vector (Promega).</p>
      </sec>
      <sec>
        <title>Analysis of Non-HLs.</title>
        <p>The six IÎºBÎ± exons were amplified as above from DNA of peripheral blood lymphocytes (&gt;80% tumor cells) of chronic lymphocytic leukemia patients (CLL1â6, 9, 10, 13â15 <xref ref-type="bib" rid="R16">16</xref>) and from the Burkitt's lymphoma cell lines BL31, BL36, BL41, BL60, BL74 (obtained from G. Lenoir, International Agency for Research on Cancer [IARC], Lyon, France), Namalwa (from M. Pawlita, Deutsches Krebsforschungszentrum [DKFZ], Heidelberg, Germany), mutu (from M. Falk, Institut fÃ¼r Klinische Molekularbiologie und Tumorgenetik, MÃ¼nchen, Germany), BJAB (from E. Kieff, Brigham and Women's Hospital, Boston, MA), and Ramos (from M. Neuberger, Medical Research Council, Cambridge, UK). To confirm a germline polymorphism in BL60 (351GâC on one allele, leading to a GlyâArg exchange at position 74 in the IÎºBÎ± protein), exon 1 was amplified from IARC277, a lymphoblastoid cell line established from the same patient.</p>
      </sec>
    </sec>
    <sec>
      <title>Results and Discussion</title>
      <p>A panel of eight HL-derived cell lines was screened for IÎºBÎ± defects by Western blot, reverse transcription PCR amplification and sequencing of IÎºBÎ± transcripts, and, if relevant, characterization of the exons of the IÎºBÎ± gene (<xref ref-type="table" rid="T1">Table </xref>). The reported defects in IÎºBÎ± protein expression in two lines (L428, KMH-2 [13]) turned out to be due to deleterious mutations in one copy of the IÎºBÎ± gene and apparent loss of the other copy, in agreement with a recent study <xref ref-type="bib" rid="R14">14</xref>. However, all other cell lines (including two not previously analyzed B lineageâderived lines) harbor wild-type IÎºBÎ± transcripts and express full-length IÎºBÎ± protein. Notably, the only cell line for which the derivation from H/RS cells is unequivocally proven (L1236 <xref ref-type="bib" rid="R17">17</xref>), expresses wild-type IÎºBÎ± from both alleles of the gene, indicating that IÎºBÎ± mutations are not present in the H/RS cells in all cases of HL, if at all. As the limited number and questionable origin of HL-derived cell lines allow no solid conclusions on this issue, we turned to the analysis of H/RS cells from tumor biopsies.</p>
      <p>Five cases of HL were chosen for analysis. In two of them (cases 4 and 5), EBV-encoded small RNA (EBER) in situ hybridization detected EBV in the H/RS cells. To determine the germline sequence of the coding parts of the IÎºBÎ± gene in the patients, DNA was extracted from whole sections of the infiltrated lymph nodes (i.e., primarily from the nonmalignant inflammatory cells in the tissue) and used for amplification and direct sequencing of the six IÎºBÎ± exons. Three deviations from the published IÎºBÎ± sequence <xref ref-type="bib" rid="R18">18</xref> were consistently found in all five cases (738G, 2111T, 2734T), while at another six positions we detected frequent germline polymorphisms (<xref ref-type="table" rid="T2">Table </xref>). For determination of the sequence of the IÎºBÎ± gene in the malignant cells, individual H/RS cells micromanipulated from immunostained histological sections were used for seminested PCR amplification. To avoid the detection of mutations introduced by Taq DNA polymerase, direct sequencing of the gel-purified PCR products was performed. In most cases â¥4 PCR products of each exon were analyzed, since the single cell PCR approach may stochastically miss either of the two copies of the gene in individual reactions.</p>
      <p>In case 1, mutations were detected in exons 1 and 4: the deletion of two and one nucleotides, respectively, leads to frameshifts (<xref ref-type="table" rid="T2">Table </xref>). Both mutations were repeatedly detected in PCR products from H/RS cells (see also <xref ref-type="table" rid="T3">Table </xref>), yet not in the germline sequences of the respective patient. We conclude that they represent clonal somatic mutations in the malignant cells. Notably, the PCR products from H/RS cells contain wild-type as well as mutant copies of the respective exons, indicating the presence of two distinct alleles of the IÎºBÎ± gene. To assign the two mutations to the two alleles, we separated the IÎºBÎ± loci of H/RS cells before coamplification of exons 1 and 4. Single H/RS cells were incubated with protease in buffer, which was then distributed to six tubes for PCR analysis. Most cells analyzed contain several copies of both wild-type and mutated exons 1 and 4 (<xref ref-type="table" rid="T3">Table </xref>), presumably due to polyploidy, a characteristic feature of H/RS cells <xref ref-type="bib" rid="R19">19</xref>. Aliquots with evidence for the presence of more than one copy of either exon were disregarded. In most other cases, the mutant exon 1 was coamplified with wild-type exon 4, and vice versa, mutant exon 4 with wild-type exon 1. We conclude that the two mutations are located on the two different alleles of the gene, implying that no full-length IÎºBÎ± protein can be synthesized in the H/RS cells. The coamplification of wild-type exons 1 and 4 in two aliquots (ID, IIIB) is apparently due to amplification of only the wild-type exons from tubes containing both wild-type and mutated copies.</p>
      <p>In case 2, a deletion of two nucleotides, leading to a frameshift, was detected in all exon 5 products amplified from the H/RS cells (<xref ref-type="table" rid="T2">Table </xref>). Again, both wild-type and mutant copies of the exon are evident in the H/RS cells, but no mutation was seen in the germline sequence. Thus, one of the two alleles of the IÎºBÎ± gene in the malignant cells is inactivated by a somatic mutation. For all other exons, the germline sequence was obtained, but an assignment of these wild-type products to either of the two alleles is not possible. Analysis of PCR products spanning exons 3â5 and 5â6, respectively (allowing discrimination of the two alleles due to the mutation in exon 5), revealed no other point mutation or deletion in that region in either of the two alleles. Since exons 1 and 2 could not be included in this analysis (see Materials and Methods), it is unclear whether the entire coding region of the second IÎºBÎ± allele is unmutated. In the third EBV-negative case (case 3), as well as in the two EBV-positive cases (cases 4 and 5), no clonal mutations in any of the IÎºBÎ± exons were detected (<xref ref-type="table" rid="T2">Table </xref>). For cases 3 and 5, we conclude that all coding exons of both alleles are unmutated, since germline polymorphisms allow their discrimination.</p>
      <p>In several PCR products amplified from the H/RS cells of cases 2â5, in particular those spanning exons 1 and 2, unique nucleotide exchanges were detected. They were not seen in any of the other products of the respective exon of the respective case, and are thus apparently not due to mutations present in all malignant cells. These mutations might indicate enhanced mutability of the IÎºBÎ± gene, reflect the genomic instability of H/RS cells <xref ref-type="bib" rid="R20">20</xref>, or be derived from Taq DNA polymerase errors (although the latter seems unlikely). Be that as it may, the frequent occurrence of this type of mutation emphasizes an important issue: one can only invoke clonal genetic defects (i.e., those that can be assigned to all malignant cells in primary tumors) as an early event in tumorigenesis. This is particularly critical in HL, as also nonneoplastic cells in the affected patients frequently harbor genetic aberrations <xref ref-type="bib" rid="R21">21</xref>. Taking this into account, IÎºBÎ± mutations found in an undefined minute cell population from a relapsed tumor <xref ref-type="bib" rid="R14">14</xref> or in only a fraction of the H/RS cells are inconclusive, in particular with respect to the role of IÎºBÎ± defects in the pathogenesis of the original tumor.</p>
      <p>To assess whether (deleterious) IÎºBÎ± mutations are frequent in other B cell lymphomas, the six exons of the IÎºBÎ± gene were analyzed in a total of 20 non-HL specimens (11 B cell chronic lymphocytic leukemias and 9 Burkitt's lymphoma cell lines; for details, see Materials and Methods). No mutations were found in any of the samples, suggesting that IÎºBÎ± mutations are not common features in these non-HLs. Since H/RS cells are derived from germinal center B cells, we have also assessed whether mutations in the IÎºBÎ± gene are frequently introduced in B cells during the germinal center reaction, as reported for the 5â² region of the bcl-6 gene <xref ref-type="bib" rid="R22">22</xref>
<xref ref-type="bib" rid="R23">23</xref>. However, no evidence for an enhanced frequency of mutations in germinal center B cells was found in the 5â² region of the IÎºBÎ± gene (exons 1 and 2), compared with naive B cells and the expected polymerase error (<xref ref-type="table" rid="T4">Table </xref>).</p>
      <p>In this study, clonal deleterious somatic mutations in the IÎºBÎ± gene were detected in the H/RS cells in two of three EBV-negative and none of two EBV-positive cases of HL. Reminiscent of the mutations in HL-derived cell lines, they lead to the synthesis of truncated IÎºBÎ± proteins lacking a part of the ankyrin repeat and/or the COOH-terminal PEST domain (<xref ref-type="fig" rid="F1">Fig. 1</xref>), which are required for interaction of IÎºB proteins with NF-ÎºB and inhibition of its DNA binding, respectively <xref ref-type="bib" rid="R24">24</xref>
<xref ref-type="bib" rid="R25">25</xref>
<xref ref-type="bib" rid="R26">26</xref>. This suggests that loss or severe impairment of these functions was selected for during the pathogenesis of the tumor cell clone: it leads to constitutive nuclear activity of NF-ÎºB. The severe phenotype of IÎºBÎ± knockout mice indicates that none of the other IÎºB family members may fully take over IÎºBÎ± function <xref ref-type="bib" rid="R27">27</xref>.</p>
      <p>Loss of IÎºBÎ± function presumably requires the inactivation of both copies of the gene. In the H/RS cells in most of the primary cases we investigated, two distinct alleles of the IÎºBÎ± gene are clearly detectable, making proof of loss of function dependent on evidence for inactivation of both of them. Our single cell PCR approach, which is dictated by the peculiar histology of HL, does allow the detection of biallelic gene inactivation in the H/RS cells (in contrast to a previous one [14]), but it misses several ways of tumor suppressor gene inactivation, such as large deletions or chromosomal translocations. In light of this, we consider the detection of three inactivating mutations in the cases studied, and evidence for loss of IÎºBÎ± function in one of these cases, to be a highly significant finding.</p>
      <p>The data presented here establish deleterious IÎºBÎ± mutations as the first recurrent genetic defect found in HL. It is intriguing that such mutations were only identified in EBV-negative cases (and lines)âa major subset of this disease for which no mechanism of transformation could be pinpointed to date. However, the limited capacity of the single cell PCR approach does not allow definite conclusions about whether IÎºBÎ± inactivation is restricted to this subset, nor about its overall frequency in HL. Our attempts to analyze a larger panel of cases by specific detection of full-length IÎºBÎ± protein in tissue sections failed, due to apparent cross-reactivity of the available antibody against the IÎºBÎ± COOH terminus (C-21; Santa Cruz Biotechnology). Certainly, not IÎºBÎ± inactivation but rather constitutive NF-ÎºB (p50/p65) activation may be the unifying feature of H/RS cells <xref ref-type="bib" rid="R8">8</xref>
<xref ref-type="bib" rid="R9">9</xref>
<xref ref-type="bib" rid="R28">28</xref>, and it may apparently be brought about by different means. The finding that H/RS cells are derived from germinal center B cells that may survive the loss of B cell receptor expression warrants testing of the role of constitutive NF-ÎºB activation in the rescue of such âcrippledâ B cells from apoptosis. Evidently, constitutive activation of NF-ÎºB (p50/p65) in the context of a B cell provides an intriguing explanation for several of the distinctive clinical and pathological features of HL. It likely precipitates the secretion of a battery of cytokines and chemokines leading to massive attraction of inflammatory cells and profound disturbances in immunoregulation, contributes to the peculiar activated phenotype of H/RS cells, and, most importantly, confers apoptosis resistance and continuous proliferation as prerequisites of malignant transformation <xref ref-type="bib" rid="R10">10</xref>
<xref ref-type="bib" rid="R11">11</xref>
<xref ref-type="bib" rid="R12">12</xref>. The tumorigenic potential of members of the NF-ÎºB family and of factors inducing NF-ÎºB activity is well established. In contrast, ex vivo proof of a tumor suppressor function of an IÎºB family member has not been provided to date (but see reference <xref ref-type="bib" rid="R29">29</xref>). This study gives evidence for recurrent inactivation of the prototypic IÎºB family member, IÎºBÎ±, in the most common lymphoma of the Western world. It will be interesting to see whether functional impairment of IÎºBs plays a role in the pathogenesis of other human malignancies.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>Case material was kindly provided by Prof. Schulz and Dr. Bohle from the Institute of Pathology, UniversitÃ¤t Giessen. We thank Ines Schwering for help during set-up of the single cell PCR, Michaela Fahrig, Julia Jesdinsky, Nadia Massoudi, Tanja Schaffer, and Christiane Gerhard for excellent technical assistance, and all members of the KÃ¼ppers lab for support and discussions.</p>
      <p>This work was supported by the Deutsche Forschungsgemeinschaft through SFB 502, the Deutsche Krebshilfe (Mildred Scheel Stiftung), and the Land Nordrhein-Westfalen. B. Jungnickel is holding a Leopoldina Postdoctoral Fellowship with support from the German Federal Ministry for Education and Science, Research and Technology (BMBF; grant no. BMBF-LPD 9801-3).</p>
      <p>
<italic>Note added in proof.</italic> In a recent study of part of the IÎºBÎ± gene in H/RS cells, Emmerich et al. (Emmerich, F., M. Meiser, M. Hummel, G. Demel, H.D. Foss, F. Jundt, S. Mathas, D. Krappmann, C. Scheidereit, H. Stein, and B. Dorken. 1999. <italic>Blood</italic>. 94:3129â3134) report a clonal monoallelic nonsense mutation in 1 of 10 cases of HL.</p>
    </ack>
    <ref-list>
      <ref id="R1">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cossman</surname><given-names>J.</given-names></name><name><surname>Messineo</surname><given-names>C.</given-names></name><name><surname>Bagg</surname><given-names>A.</given-names></name></person-group>
<article-title>Reed-Sternberg cellsurvival in a hostile sea</article-title>
<source>Lab. Invest</source>
<volume>78</volume>
<year>1998</year>
<fpage>229</fpage>
<lpage>235</lpage>
<?supplied-pmid 9520936?><pub-id pub-id-type="pmid">9520936</pub-id></element-citation>
      </ref>
      <ref id="R2">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Simons</surname><given-names>G.</given-names></name><name><surname>Laumann</surname><given-names>R.</given-names></name><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Hansmann</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Hodgkin diseaseHodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development</article-title>
<source>Proc. Natl. Acad. Sci. USA.</source>
<volume>91</volume>
<year>1994</year>
<fpage>10962</fpage>
<lpage>10966</lpage>
<?supplied-pmid 7971992?><pub-id pub-id-type="pmid">7971992</pub-id></element-citation>
      </ref>
      <ref id="R3">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanzler</surname><given-names>H.</given-names></name><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name><name><surname>Hansmann</surname><given-names>M.L.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name></person-group>
<article-title>Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells</article-title>
<source>J. Exp. Med.</source>
<volume>184</volume>
<year>1996</year>
<fpage>1495</fpage>
<lpage>1505</lpage>
<?supplied-pmid 8879220?><pub-id pub-id-type="pmid">8879220</pub-id></element-citation>
      </ref>
      <ref id="R4">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajewsky</surname><given-names>K.</given-names></name></person-group>
<article-title>Clonal selection and learning in the antibody system</article-title>
<source>Nature.</source>
<volume>381</volume>
<year>1996</year>
<fpage>751</fpage>
<lpage>758</lpage>
<?supplied-pmid 8657279?><pub-id pub-id-type="pmid">8657279</pub-id></element-citation>
      </ref>
      <ref id="R5">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montesinos-Rongen</surname><given-names>M.</given-names></name><name><surname>Roers</surname><given-names>A.</given-names></name><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Hansmann</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease</article-title>
<source>Blood.</source>
<volume>94</volume>
<year>1999</year>
<fpage>1755</fpage>
<lpage>1760</lpage>
<?supplied-pmid 10477701?><pub-id pub-id-type="pmid">10477701</pub-id></element-citation>
      </ref>
      <ref id="R6">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gravel</surname><given-names>S.</given-names></name><name><surname>Delsol</surname><given-names>G.</given-names></name><name><surname>Al Saati</surname><given-names>T.</given-names></name></person-group>
<article-title>Single-cell analysis of the t(14,18)(q31,q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells</article-title>
<source>Blood.</source>
<volume>91</volume>
<year>1998</year>
<fpage>2866</fpage>
<lpage>2874</lpage>
<?supplied-pmid 9531597?><pub-id pub-id-type="pmid">9531597</pub-id></element-citation>
      </ref>
      <ref id="R7">
        <element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Armbinder</surname><given-names>R.F.</given-names></name><name><surname>Weiss</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Association of Epstein-Barr virus with Hodgkin's disease</article-title>
<person-group person-group-type="editor"><name><surname>Mauch</surname><given-names>P.M.</given-names></name><name><surname>Armitage</surname><given-names>J.O.</given-names></name><name><surname>Diehl</surname><given-names>V.</given-names></name><name><surname>Hoppe</surname><given-names>R.T.</given-names></name><name><surname>Weiss</surname><given-names>L.M.</given-names></name></person-group>
<source>Hodgkin's Disease</source>
<year>1999</year>
<fpage>79</fpage>
<lpage>98</lpage>
<publisher-name>Lippincott Williams and Wilkins</publisher-name>
<publisher-loc>Philadelphia</publisher-loc>
</element-citation>
      </ref>
      <ref id="R8">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bargou</surname><given-names>R.C.</given-names></name><name><surname>Leng</surname><given-names>C.</given-names></name><name><surname>Krappmann</surname><given-names>D.</given-names></name><name><surname>Emmerich</surname><given-names>F.</given-names></name><name><surname>Mapara</surname><given-names>M.Y.</given-names></name><name><surname>Bommert</surname><given-names>K.</given-names></name><name><surname>Royer</surname><given-names>H.D.</given-names></name><name><surname>Scheidereit</surname><given-names>C.</given-names></name><name><surname>DÃ¶rken</surname><given-names>B.</given-names></name></person-group>
<article-title>High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells</article-title>
<source>Blood.</source>
<volume>87</volume>
<year>1996</year>
<fpage>4340</fpage>
<lpage>4347</lpage>
<?supplied-pmid 8639794?><pub-id pub-id-type="pmid">8639794</pub-id></element-citation>
      </ref>
      <ref id="R9">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bargou</surname><given-names>R.C.</given-names></name><name><surname>Emmerich</surname><given-names>F.</given-names></name><name><surname>Krappmann</surname><given-names>D.</given-names></name><name><surname>Bommert</surname><given-names>K.</given-names></name><name><surname>Mapara</surname><given-names>M.Y.</given-names></name><name><surname>Arnold</surname><given-names>W.</given-names></name><name><surname>Royer</surname><given-names>H.D.</given-names></name><name><surname>Grinstein</surname><given-names>E.</given-names></name><name><surname>Greiner</surname><given-names>A.</given-names></name><name><surname>Scheidereit</surname><given-names>C.</given-names></name><name><surname>DÃ¶rken</surname><given-names>B.</given-names></name></person-group>
<article-title>Constitutive nuclear factor-kappaBâRelA activation is required for proliferation and survival of Hodgkin's disease tumor cells</article-title>
<source>J. Clin. Invest</source>
<volume>100</volume>
<year>1997</year>
<fpage>2961</fpage>
<lpage>2969</lpage>
<?supplied-pmid 9399941?><pub-id pub-id-type="pmid">9399941</pub-id></element-citation>
      </ref>
      <ref id="R10">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>A.S.</given-names></name></person-group>
<article-title>The NF-ÎºB and IÎºB proteinsnew discoveries and insights</article-title>
<source>Annu. Rev. Immunol.</source>
<volume>14</volume>
<year>1996</year>
<fpage>649</fpage>
<lpage>681</lpage>
<?supplied-pmid 8717528?><pub-id pub-id-type="pmid">8717528</pub-id></element-citation>
      </ref>
      <ref id="R11">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wulczyn</surname><given-names>F.G.</given-names></name><name><surname>Krappmann</surname><given-names>D.</given-names></name><name><surname>Scheidereit</surname><given-names>C.</given-names></name></person-group>
<article-title>The NF-kappa B/Rel and I kappa B gene familiesmediators of immune response and inflammation</article-title>
<source>J. Mol. Med.</source>
<volume>74</volume>
<year>1996</year>
<fpage>749</fpage>
<lpage>769</lpage>
<?supplied-pmid 8974017?><pub-id pub-id-type="pmid">8974017</pub-id></element-citation>
      </ref>
      <ref id="R12">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luque</surname><given-names>I.</given-names></name><name><surname>Gelinas</surname><given-names>C.</given-names></name></person-group>
<article-title>Rel/NF-kappa B and I kappa B factors in oncogenesis</article-title>
<source>Semin. Cancer Biol.</source>
<volume>8</volume>
<year>1997</year>
<fpage>103</fpage>
<lpage>111</lpage>
<?supplied-pmid 9299588?><pub-id pub-id-type="pmid">9299588</pub-id></element-citation>
      </ref>
      <ref id="R13">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>K.M.</given-names></name><name><surname>Roff</surname><given-names>M.</given-names></name><name><surname>Hay</surname><given-names>R.T.</given-names></name></person-group>
<article-title>Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB</article-title>
<source>Oncogene.</source>
<volume>16</volume>
<year>1998</year>
<fpage>2131</fpage>
<lpage>2139</lpage>
<?supplied-pmid 9572494?><pub-id pub-id-type="pmid">9572494</pub-id></element-citation>
      </ref>
      <ref id="R14">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cabannes</surname><given-names>E.</given-names></name><name><surname>Khan</surname><given-names>G.</given-names></name><name><surname>Aillet</surname><given-names>F.</given-names></name><name><surname>Jarrett</surname><given-names>R.F.</given-names></name><name><surname>Hay</surname><given-names>R.T.</given-names></name></person-group>
<article-title>Mutations in the IÎºBÎ± gene in Hodgkin's disease suggest a tumour suppressor role for IÎºBÎ±</article-title>
<source>Oncogene.</source>
<volume>18</volume>
<year>1999</year>
<fpage>3063</fpage>
<lpage>3070</lpage>
<?supplied-pmid 10340377?><pub-id pub-id-type="pmid">10340377</pub-id></element-citation>
      </ref>
      <ref id="R15">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drexler</surname><given-names>H.G.</given-names></name></person-group>
<article-title>Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines</article-title>
<source>Leuk. Lymphoma.</source>
<volume>9</volume>
<year>1993</year>
<fpage>1</fpage>
<lpage>25</lpage>
<?supplied-pmid 7682880?><pub-id pub-id-type="pmid">7682880</pub-id></element-citation>
      </ref>
      <ref id="R16">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Hansmann</surname><given-names>M.L.</given-names></name></person-group>
<article-title>Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction</article-title>
<source>Am. J. Pathol.</source>
<volume>143</volume>
<year>1993</year>
<fpage>230</fpage>
<lpage>239</lpage>
<?supplied-pmid 8317549?><pub-id pub-id-type="pmid">8317549</pub-id></element-citation>
      </ref>
      <ref id="R17">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanzler</surname><given-names>H.</given-names></name><name><surname>Hansmann</surname><given-names>M.L.</given-names></name><name><surname>Kapp</surname><given-names>U.</given-names></name><name><surname>Wolf</surname><given-names>J.</given-names></name><name><surname>Diehl</surname><given-names>V.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name></person-group>
<article-title>Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient</article-title>
<source>Blood.</source>
<volume>87</volume>
<year>1996</year>
<fpage>3429</fpage>
<lpage>3436</lpage>
<?supplied-pmid 8605361?><pub-id pub-id-type="pmid">8605361</pub-id></element-citation>
      </ref>
      <ref id="R18">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito</surname><given-names>C.Y.</given-names></name><name><surname>Adey</surname><given-names>N.</given-names></name><name><surname>Bautch</surname><given-names>V.L.</given-names></name><name><surname>Baldwin</surname><given-names>A.S.J.</given-names></name></person-group>
<article-title>Structure and evolution of the human IKBA gene</article-title>
<source>Genomics.</source>
<volume>29</volume>
<year>1995</year>
<fpage>490</fpage>
<lpage>495</lpage>
<?supplied-pmid 8666399?><pub-id pub-id-type="pmid">8666399</pub-id></element-citation>
      </ref>
      <ref id="R19">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weber-Matthiesen</surname><given-names>K.</given-names></name><name><surname>Deerberg</surname><given-names>J.</given-names></name><name><surname>Poetsch</surname><given-names>M.</given-names></name><name><surname>Grote</surname><given-names>W.</given-names></name><name><surname>Schlegelberger</surname><given-names>B.</given-names></name></person-group>
<article-title>Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease</article-title>
<source>Blood.</source>
<volume>86</volume>
<year>1995</year>
<fpage>1464</fpage>
<lpage>1468</lpage>
<?supplied-pmid 7632954?><pub-id pub-id-type="pmid">7632954</pub-id></element-citation>
      </ref>
      <ref id="R20">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Falzetti</surname><given-names>D.</given-names></name><name><surname>Crescenzi</surname><given-names>B.</given-names></name><name><surname>Matteuci</surname><given-names>C.</given-names></name><name><surname>Falini</surname><given-names>B.</given-names></name><name><surname>Martelli</surname><given-names>M.F.</given-names></name><name><surname>Van Den Berghe</surname><given-names>H.</given-names></name><name><surname>Mecucci</surname><given-names>C.</given-names></name></person-group>
<article-title>Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease</article-title>
<source>Haematologica.</source>
<volume>84</volume>
<year>1999</year>
<fpage>298</fpage>
<lpage>305</lpage>
<?supplied-pmid 10190942?><pub-id pub-id-type="pmid">10190942</pub-id></element-citation>
      </ref>
      <ref id="R21">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrios</surname><given-names>L.</given-names></name><name><surname>Caballin</surname><given-names>M.R.</given-names></name><name><surname>Miro</surname><given-names>R.</given-names></name><name><surname>Fuster</surname><given-names>C.</given-names></name><name><surname>Berrozpe</surname><given-names>G.</given-names></name><name><surname>Subias</surname><given-names>A.</given-names></name><name><surname>Batlle</surname><given-names>X.</given-names></name><name><surname>Egozcue</surname><given-names>J.</given-names></name></person-group>
<article-title>Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome instability</article-title>
<source>Hum. Genet.</source>
<volume>78</volume>
<year>1988</year>
<fpage>320</fpage>
<lpage>324</lpage>
<?supplied-pmid 3360446?><pub-id pub-id-type="pmid">3360446</pub-id></element-citation>
      </ref>
      <ref id="R22">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>H.M.</given-names></name><name><surname>Peters</surname><given-names>A.</given-names></name><name><surname>Baron</surname><given-names>B.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Storb</surname><given-names>U.</given-names></name></person-group>
<article-title>Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes</article-title>
<source>Science.</source>
<volume>280</volume>
<year>1998</year>
<fpage>1750</fpage>
<lpage>1752</lpage>
<?supplied-pmid 9624052?><pub-id pub-id-type="pmid">9624052</pub-id></element-citation>
      </ref>
      <ref id="R23">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pasqualucci</surname><given-names>L.</given-names></name><name><surname>Migliazza</surname><given-names>A.</given-names></name><name><surname>Fracchiolla</surname><given-names>N.</given-names></name><name><surname>William</surname><given-names>C.</given-names></name><name><surname>Neri</surname><given-names>A.</given-names></name><name><surname>Baldini</surname><given-names>L.</given-names></name><name><surname>Chaganti</surname><given-names>R.S.K.</given-names></name><name><surname>Klein</surname><given-names>U.</given-names></name><name><surname>KÃ¼ppers</surname><given-names>R.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Dalla-Favera</surname><given-names>R.</given-names></name></person-group>
<article-title>BCL-6 mutations in normal germinal center B cellsevidence of somatic hypermutation acting outside Ig loci</article-title>
<source>Proc. Natl. Acad. Sci. USA.</source>
<volume>95</volume>
<year>1998</year>
<fpage>11816</fpage>
<lpage>11821</lpage>
<?supplied-pmid 9751748?><pub-id pub-id-type="pmid">9751748</pub-id></element-citation>
      </ref>
      <ref id="R24">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huxford</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>D.B.</given-names></name><name><surname>Malek</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>G.</given-names></name></person-group>
<article-title>The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation</article-title>
<source>Cell.</source>
<volume>95</volume>
<year>1998</year>
<fpage>759</fpage>
<lpage>770</lpage>
<?supplied-pmid 9865694?><pub-id pub-id-type="pmid">9865694</pub-id></element-citation>
      </ref>
      <ref id="R25">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>M.D.</given-names></name><name><surname>Harrison</surname><given-names>S.C.</given-names></name></person-group>
<article-title>Structure of an IkappaBalpha/NF-kappaB complex</article-title>
<source>Cell.</source>
<volume>95</volume>
<year>1998</year>
<fpage>749</fpage>
<lpage>758</lpage>
<?supplied-pmid 9865693?><pub-id pub-id-type="pmid">9865693</pub-id></element-citation>
      </ref>
      <ref id="R26">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ernst</surname><given-names>M.K.</given-names></name><name><surname>Dunn</surname><given-names>L.L.</given-names></name><name><surname>Rice</surname><given-names>N.R.</given-names></name></person-group>
<article-title>The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers</article-title>
<source>Mol. Cell. Biol.</source>
<volume>15</volume>
<year>1995</year>
<fpage>872</fpage>
<lpage>882</lpage>
<?supplied-pmid 7823953?><pub-id pub-id-type="pmid">7823953</pub-id></element-citation>
      </ref>
      <ref id="R27">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beg</surname><given-names>A.A.</given-names></name><name><surname>Sha</surname><given-names>W.C.</given-names></name><name><surname>Bronson</surname><given-names>R.T.</given-names></name><name><surname>Baltimore</surname><given-names>D.</given-names></name></person-group>
<article-title>Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice</article-title>
<source>Genes Dev.</source>
<volume>9</volume>
<year>1995</year>
<fpage>2736</fpage>
<lpage>2746</lpage>
<?supplied-pmid 7590249?><pub-id pub-id-type="pmid">7590249</pub-id></element-citation>
      </ref>
      <ref id="R28">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krappmann</surname><given-names>D.</given-names></name><name><surname>Emmerich</surname><given-names>F.</given-names></name><name><surname>Kordes</surname><given-names>U.</given-names></name><name><surname>Scharschmidt</surname><given-names>E.</given-names></name><name><surname>DÃ¶rken</surname><given-names>B.</given-names></name><name><surname>Scheidereit</surname><given-names>C.</given-names></name></person-group>
<article-title>Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells</article-title>
<source>Oncogene.</source>
<volume>18</volume>
<year>1999</year>
<fpage>943</fpage>
<lpage>953</lpage>
<?supplied-pmid 10023670?><pub-id pub-id-type="pmid">10023670</pub-id></element-citation>
      </ref>
      <ref id="R29">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beauparlant</surname><given-names>P.</given-names></name><name><surname>Kwan</surname><given-names>I.</given-names></name><name><surname>Bitar</surname><given-names>R.</given-names></name><name><surname>Chou</surname><given-names>P.</given-names></name><name><surname>Koromilas</surname><given-names>A.E.</given-names></name><name><surname>Sonenberg</surname><given-names>N.</given-names></name><name><surname>Hiscott</surname><given-names>J.</given-names></name></person-group>
<article-title>Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation</article-title>
<source>Oncogene.</source>
<volume>9</volume>
<year>1994</year>
<fpage>3189</fpage>
<lpage>3197</lpage>
<?supplied-pmid 7936641?><pub-id pub-id-type="pmid">7936641</pub-id></element-citation>
      </ref>
      <ref id="R30">
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haskill</surname><given-names>S.</given-names></name><name><surname>Beg</surname><given-names>A.A.</given-names></name><name><surname>Tompkins</surname><given-names>S.M.</given-names></name><name><surname>Morris</surname><given-names>J.S.</given-names></name><name><surname>Yurochko</surname><given-names>A.D.</given-names></name><name><surname>Sampson-Johannes</surname><given-names>A.</given-names></name><name><surname>Mondal</surname><given-names>K.</given-names></name><name><surname>Ralph</surname><given-names>P.</given-names></name><name><surname>Baldwin</surname><given-names>A.S.J.</given-names></name></person-group>
<article-title>Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity</article-title>
<source>Cell.</source>
<volume>65</volume>
<year>1991</year>
<fpage>1281</fpage>
<lpage>1289</lpage>
<?supplied-pmid 1829648?><pub-id pub-id-type="pmid">1829648</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Analysis of the IÎºBÎ± Protein, Transcripts, and Gene in HL-derived Cell Lines</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr valign="bottom">
            <th align="left" rowspan="1" colspan="1"/>
            <th align="center" rowspan="1" colspan="1"/>
            <th align="center" rowspan="1" colspan="1"/>
            <th align="center" colspan="2" rowspan="1">IÎºBÎ± transcripts</th>
            <th align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <th align="left" rowspan="1" colspan="1">Cell line</th>
            <th align="center" rowspan="1" colspan="1">Origin/EBV status</th>
            <th align="center" rowspan="1" colspan="1">Full-length IÎºBÎ± protein</th>
            <th align="center" rowspan="1" colspan="1">Polymorphisms</th>
            <th align="center" rowspan="1" colspan="1">Aberrations</th>
            <th align="center" rowspan="1" colspan="1">Mutations in IÎºBÎ± gene</th>
          </tr>
        </thead>
        <tbody>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">L428</td>
            <td align="center" rowspan="1" colspan="1">B/â</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1">175C, 399C, 1049C</td>
            <td align="char" char="." rowspan="1" colspan="1">893CâU</td>
            <td align="char" char="." rowspan="1" colspan="1">2278CâT</td>
          </tr>
          <tr valign="top">
            <td align="left" rowspan="1" colspan="1">KMH-2</td>
            <td align="center" rowspan="1" colspan="1">B/â</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1">175C, 399C, 1049C</td>
            <td align="center" rowspan="1" colspan="1">Del. 509â641 Ins. UCCAG</td>
            <td align="center" rowspan="1" colspan="1">Del. 1497â1710</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">L1236</td>
            <td align="center" rowspan="1" colspan="1">B/â</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175Y, 399C, 1049U</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">DEV</td>
            <td align="center" rowspan="1" colspan="1">B/â</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175Y, 399C, 1049C</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">L591</td>
            <td align="center" rowspan="1" colspan="1">B/+</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175U, 399C, 1049U</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">L540</td>
            <td align="center" rowspan="1" colspan="1">T/â</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175U, 399C, 1049Y</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">HDLM-2</td>
            <td align="center" rowspan="1" colspan="1">T/â</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175C, 399C, 1049U</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">HD-MyZ</td>
            <td align="center" rowspan="1" colspan="1">Myeloid/â</td>
            <td align="center" rowspan="1" colspan="1">+</td>
            <td align="center" rowspan="1" colspan="1">175C, 399U, 1049C</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="center" rowspan="1" colspan="1"/>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>These sequence data are available from GenBank/EMBL/DDBJ under accession nos. AJ249290 and AJ249291.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" position="float">
      <label>Table 2</label>
      <caption>
        <p>Sequence Analysis of the IÎºBÎ± Exons Amplified from Tissue Sections and Single H/RS Cells</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr valign="bottom">
            <th align="left" rowspan="1" colspan="1">Case</th>
            <th align="center" rowspan="1" colspan="1">Exon</th>
            <th align="center" rowspan="1" colspan="1">Polymorphisms</th>
            <th align="center" rowspan="1" colspan="1">PCR-positive cells</th>
            <th align="center" rowspan="1" colspan="1">Products sequenced</th>
            <th align="left" rowspan="1" colspan="1">Mutations in H/RS cells</th>
            <th align="left" rowspan="1" colspan="1">Alleles amplified</th>
          </tr>
        </thead>
        <tbody>
          <tr valign="bottom">
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">212C</td>
            <td align="char" char="." rowspan="1" colspan="1">2/5</td>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="left" rowspan="1" colspan="1">Deletion (254â255)</td>
            <td align="char" char="." rowspan="1" colspan="1">2WT/M</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1059C</td>
            <td align="char" char="." rowspan="1" colspan="1">2/5</td>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1678G</td>
            <td align="char" char="." rowspan="1" colspan="1">5/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">2025C</td>
            <td align="char" char="." rowspan="1" colspan="1">6/8</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">Deletion (1994)</td>
            <td align="left" rowspan="1" colspan="1">2WT, 1M, 3WT/M</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="char" char="." rowspan="1" colspan="1">6/8</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="char" char="." rowspan="1" colspan="1">2787T</td>
            <td align="char" char="." rowspan="1" colspan="1">4/8</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2921A</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">212C</td>
            <td align="char" char="." rowspan="1" colspan="1">7/37</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1059T</td>
            <td align="char" char="." rowspan="1" colspan="1">8/37</td>
            <td align="char" char="." rowspan="1" colspan="1">8</td>
            <td align="char" char="." rowspan="1" colspan="1">2 unique mutations</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1678G</td>
            <td align="char" char="." rowspan="1" colspan="1">5/14</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">2025C</td>
            <td align="char" char="." rowspan="1" colspan="1">5/14</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="char" char="." rowspan="1" colspan="1">5/14</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">Deletion (2355â2356)</td>
            <td align="char" char="." rowspan="1" colspan="1">5WT/M</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="char" char="." rowspan="1" colspan="1">2787C</td>
            <td align="char" char="." rowspan="1" colspan="1">4/14</td>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2921G</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">212Y</td>
            <td align="char" char="." rowspan="1" colspan="1">8/26</td>
            <td align="char" char="." rowspan="1" colspan="1">7</td>
            <td align="left" rowspan="1" colspan="1">51CâT in 1 seq.</td>
            <td align="left" rowspan="1" colspan="1">2C, 3T, 2Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1059Y</td>
            <td align="char" char="." rowspan="1" colspan="1">5/26</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">4C, 1T</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1678R</td>
            <td align="char" char="." rowspan="1" colspan="1">6/8</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">2A, 4G</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">2025Y</td>
            <td align="char" char="." rowspan="1" colspan="1">5/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">4C, 1T</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="char" char="." rowspan="1" colspan="1">5/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">â</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="char" char="." rowspan="1" colspan="1">2787Y</td>
            <td align="char" char="." rowspan="1" colspan="1">6/8</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">4T, 1C, 1Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2921R</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">4A, 1G, 1R</td>
          </tr>
          <tr valign="bottom">
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">212T</td>
            <td align="char" char="." rowspan="1" colspan="1">5/12</td>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="left" rowspan="1" colspan="1">52CâT in 1 seq.</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1059C</td>
            <td align="char" char="." rowspan="1" colspan="1">6/12</td>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1678G</td>
            <td align="char" char="." rowspan="1" colspan="1">5/10</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">2025C</td>
            <td align="char" char="." rowspan="1" colspan="1">7/10</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="char" char="." rowspan="1" colspan="1">7/10</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="char" char="." rowspan="1" colspan="1">2787T</td>
            <td align="char" char="." rowspan="1" colspan="1">7/10</td>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2921A</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">212Y</td>
            <td align="char" char="." rowspan="1" colspan="1">8/17</td>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">1T, 3Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2</td>
            <td align="char" char="." rowspan="1" colspan="1">1059Y</td>
            <td align="char" char="." rowspan="1" colspan="1">7/17</td>
            <td align="char" char="." rowspan="1" colspan="1">7</td>
            <td align="char" char="." rowspan="1" colspan="1">6 unique mutations</td>
            <td align="left" rowspan="1" colspan="1">4T, 3Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">3</td>
            <td align="char" char="." rowspan="1" colspan="1">1678R</td>
            <td align="char" char="." rowspan="1" colspan="1">7/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">1A, 1G, 3R</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="char" char="." rowspan="1" colspan="1">2025Y</td>
            <td align="char" char="." rowspan="1" colspan="1">5/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">3C, 1T, 1Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">â</td>
            <td align="char" char="." rowspan="1" colspan="1">7/8</td>
            <td align="char" char="." rowspan="1" colspan="1">5</td>
            <td align="left" rowspan="1" colspan="1">â</td>
            <td align="left" rowspan="1" colspan="1">â</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">6</td>
            <td align="char" char="." rowspan="1" colspan="1">2787Y</td>
            <td align="char" char="." rowspan="1" colspan="1">5/8</td>
            <td align="char" char="." rowspan="1" colspan="1">4</td>
            <td align="left" rowspan="1" colspan="1">3035GâA in 1 seq.</td>
            <td align="left" rowspan="1" colspan="1">1C, 3Y</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">2921R</td>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1G, 3R</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>These sequence data are available from GenBank/EMBL/DDBJ under accession nos. AJ249283âAJ249289 and AJ249294âAJ249295. seq., sequence.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T3" position="float">
      <label>Table 3</label>
      <caption>
        <p>Analysis of IÎºBÎ± Exons 1 and 4 Amplified from Aliquots of Genomic DNA from Single H/RS Cells of Case 1</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr valign="bottom" align="center">
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1">I</th>
            <th rowspan="1" colspan="1">II</th>
            <th rowspan="1" colspan="1">III</th>
            <th rowspan="1" colspan="1">IV</th>
            <th rowspan="1" colspan="1">V</th>
          </tr>
        </thead>
        <tbody>
          <tr valign="bottom">
            <td align="center" rowspan="1" colspan="1">A</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1WT 4Mut</td>
            <td align="left" rowspan="1" colspan="1">1WT 4both</td>
            <td align="left" rowspan="1" colspan="1">1WT 4Mut</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="center" rowspan="1" colspan="1">B</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1WT 4Mut</td>
            <td align="left" rowspan="1" colspan="1">1WT 4WT</td>
            <td align="char" char="." rowspan="1" colspan="1">1WT</td>
            <td align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr valign="bottom">
            <td align="center" rowspan="1" colspan="1">C</td>
            <td align="left" rowspan="1" colspan="1">1Mut 4WT</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1WT 4both</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1WT 4both</td>
          </tr>
          <tr valign="bottom">
            <td align="center" rowspan="1" colspan="1">D</td>
            <td align="left" rowspan="1" colspan="1">1WT 4WT</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">1both</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="char" char="." rowspan="1" colspan="1">1WT</td>
          </tr>
          <tr valign="bottom">
            <td align="center" rowspan="1" colspan="1">E</td>
            <td align="left" rowspan="1" colspan="1">1both 4WT</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1both 4both</td>
            <td align="left" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">1Mut 4WT</td>
          </tr>
          <tr valign="bottom" align="left">
            <td rowspan="1" colspan="1">F</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">1Mut 4WT</td>
            <td rowspan="1" colspan="1"/>
            <td rowspan="1" colspan="1">1Mut 4WT</td>
            <td rowspan="1" colspan="1">1WT 4Mut</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Five cells (IâV) out of eight analyzed in this experiment yielded PCR products for exons 1 and 4 in more than one of the six aliquots (AâF). Sequence analysis of the products revealed wild-type (WT), mutant (Mut), or mixed (both) sequences for exon 1 and 4, respectively. Negative control reactions yielded no products for either exon.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T4" position="float">
      <label>Table 4</label>
      <caption>
        <p>Analysis of IÎºBÎ± Exons 1 and 2 in Normal B Cells</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr valign="bottom">
            <th align="left" rowspan="1" colspan="1">PCR product</th>
            <th align="center" rowspan="1" colspan="1">Cell population</th>
            <th align="center" rowspan="1" colspan="1">No. of sequences</th>
            <th align="center" rowspan="1" colspan="1">Basepairs sequenced</th>
            <th align="center" rowspan="1" colspan="1">No. of mutations</th>
            <th align="left" rowspan="1" colspan="1">Mutation frequency</th>
          </tr>
        </thead>
        <tbody>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1"/>
            <td align="left" rowspan="1" colspan="1">%</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">V<sub>H</sub>3 rearr.</td>
            <td align="center" rowspan="1" colspan="1">Naive</td>
            <td align="char" char="." rowspan="1" colspan="1">17</td>
            <td align="char" char="." rowspan="1" colspan="1">3,253</td>
            <td align="char" char="." rowspan="1" colspan="1">0</td>
            <td align="char" char="." rowspan="1" colspan="1">0</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">GC</td>
            <td align="char" char="." rowspan="1" colspan="1">13</td>
            <td align="char" char="." rowspan="1" colspan="1">2,543</td>
            <td align="char" char="." rowspan="1" colspan="1">135</td>
            <td align="char" char="." rowspan="1" colspan="1">5.3</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">IÎºBÎ± exon 1</td>
            <td align="center" rowspan="1" colspan="1">Naive</td>
            <td align="char" char="." rowspan="1" colspan="1">24</td>
            <td align="char" char="." rowspan="1" colspan="1">10,752</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">0.009</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1"/>
            <td align="center" rowspan="1" colspan="1">GC</td>
            <td align="char" char="." rowspan="1" colspan="1">25</td>
            <td align="char" char="." rowspan="1" colspan="1">11,200</td>
            <td align="char" char="." rowspan="1" colspan="1">1</td>
            <td align="char" char="." rowspan="1" colspan="1">0.009</td>
          </tr>
          <tr valign="bottom">
            <td align="left" rowspan="1" colspan="1">IÎºBÎ± exon 2</td>
            <td align="center" rowspan="1" colspan="1">GC</td>
            <td align="char" char="." rowspan="1" colspan="1">22</td>
            <td align="char" char="." rowspan="1" colspan="1">9,482</td>
            <td align="char" char="." rowspan="1" colspan="1">0</td>
            <td align="char" char="." rowspan="1" colspan="1">0</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>VH3 gene rearrangements and exons 1 and 2 of the IÎºBÎ± gene were amplified from genomic DNA of naive (CD27<sup>â</sup>IgD<sup>+</sup>) and germinal center (GC, CD77<sup>+</sup>) B cells, cloned, and analyzed for somatic mutations. The expected frequency of mutations induced by Pfu DNA polymerase is 0.0035% (10<sup>â6</sup> mutations/bp/cycle Pfu DNA polymerase error Ã 35 cycles).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>IÎºBÎ± defects in HL. The structure of the IÎºBÎ± gene (top; the amplified regions spanning exons 1â6 are bold, and translation start and stop codons are given) is correlated with the structure of the IÎºBÎ± protein (bottom; the six ankyrin repeats and the PEST domain are indicated). The positions of the mutations detected in H/RS cells of primary cases, as well as those detected in cell lines, are shown.</p>
      </caption>
      <graphic xlink:href="JEM991554.f1"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>